At technical conferences it's normal to have the scientists make the presentations, not the management. In this case the lead clinician, and developer of the vaccine is leading the presentation, which is completely appropriate.
After SNO I would expect management to attend a variety of Investor's Conferences and present a corporate presentation on the opportunity the company presents to investors. I believe the share price will be substantially higher and we'll be invited to major conferences, like the J.P. Morgan Healthcare Conference in early January. That's probably the biggest such conference annually.
Gary